{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:34:05Z","timestamp":1768739645200,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Age-related macular degeneration (AMD) is the eye disease with the highest epidemic incidence, and has great impact on the aged population. Wet-type AMD commonly has the feature of neovascularization, which destroys the normal retinal structure and visual function. So far, effective therapy options for rescuing visual function in advanced AMD patients are highly limited, especially in wet-type AMD, in which the retinal pigmented epithelium and Bruch\u2019s membrane structure (RPE-BM) are destroyed by abnormal angiogenesis. Anti-VEGF treatment is an effective remedy for the latter type of AMD; however, it is not a curative therapy. Therefore, reconstruction of the complex structure of RPE-BM and controlled release of angiogenesis inhibitors are strongly required for sustained therapy. The major purpose of this study was to develop a dual function biomimetic material, which could mimic the RPE-BM structure and ensure slow release of angiogenesis inhibitor as a novel therapeutic strategy for wet AMD. We herein utilized plasma-modified polydimethylsiloxane (PDMS) sheet to create a biomimetic scaffold mimicking subretinal BM. This dual-surface biomimetic scaffold was coated with laminin and dexamethasone-loaded liposomes. The top surface of PDMS was covalently grafted with laminin and used for cultivation of the retinal pigment epithelial cells differentiated from human induced pluripotent stem cells (hiPSC-RPE). To reach the objective of inhibiting angiogenesis required for treatment of wet AMD, the bottom surface of modified PDMS membrane was further loaded with dexamethasone-containing liposomes via biotin-streptavidin linkage. We demonstrated that hiPSC-RPE cells could proliferate, express normal RPE-specific genes and maintain their phenotype on laminin-coated PDMS membrane, including phagocytosis ability, and secretion of anti-angiogenesis factor PEDF. By using in vitro HUVEC angiogenesis assay, we showed that application of our membrane could suppress oxidative stress-induced angiogenesis, which was manifested in decreased secretion of VEGF by RPE cells and suppression of vascularization. In conclusion, we propose modified biomimetic material for dual delivery of RPE cells and liposome-enveloped dexamethasone, which can be potentially applied for AMD therapy.<\/jats:p>","DOI":"10.3390\/ijms20020241","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T03:22:31Z","timestamp":1547090551000},"page":"241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization"],"prefix":"10.3390","volume":"20","author":[{"given":"Tzu-Wei","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh","family":"Chien","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan"},{"name":"Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-9131","authenticated-orcid":false,"given":"Mong-Lien","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan"},{"name":"Facility of Medicine, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliaksandr A.","family":"Yarmishyn","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Kuang","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan"},{"name":"Department of Public Health and Institute of Public Health, National Yang-Ming University, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hsien","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shin Kong Wu Ho-Su Memorial Hospital &amp; Fu-Jen Catholic University, Taipei 11101, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang-Ming University, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-2999","authenticated-orcid":false,"given":"Chih-Chien","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang-Ming University, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Jen","family":"Chen","sequence":"additional","affiliation":[{"name":"Facility of Medicine, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan"},{"name":"Department of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Hung","family":"Chien","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan"},{"name":"Department of Ophthalmology, Tri-Service General Hospital and National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss: Areds report no. 8. Arch. Ophthalmol., 119, 1417\u20131436.","DOI":"10.1001\/archopht.119.10.1417"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1172\/JCI42437","article-title":"Therapeutic targets in age-related macular disease","volume":"120","author":"Bird","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of vegf and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.81.2.154","article-title":"Increased expression of angiogenic growth factors in age-related maculopathy","volume":"81","author":"Kliffen","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/08820538.2011.577130","article-title":"Review of combination therapies for neovascular age-related macular degeneration","volume":"26","author":"Couch","year":"2011","journal-title":"Semin. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/ICU.0b013e328352411c","article-title":"Preferred therapies for neovascular age-related macular degeneration","volume":"23","author":"Lally","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","article-title":"Inhibition of platelet-derived growth factor b signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization","volume":"168","author":"Jo","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1167\/iovs.12-11239","article-title":"Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: Improved survival when implanted as a monolayer","volume":"54","author":"Diniz","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"Fynes","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"eaao4097","DOI":"10.1126\/scitranslmed.aao4097","article-title":"A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration","volume":"10","author":"Kashani","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"64631","DOI":"10.18632\/oncotarget.11502","article-title":"Laminin modification subretinal bio-scaffold remodels retinal pigment epithelium-driven microenvironment in vitro and in vivo","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/2474126416683299","article-title":"Simultaneous dexamethasone intravitreal implant and anti-vegf therapy for neovascular age-related macular degeneration resistant to anti-vegf monotherapy","volume":"1","author":"Todorich","year":"2017","journal-title":"J. Vitreoretin. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/10717540701603530","article-title":"Dexamethasone incorporating liposomes: Effect of lipid composition on drug trapping efficiency and vesicle stability","volume":"14","author":"Tsotas","year":"2007","journal-title":"Drug Deliv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pros.22963","article-title":"Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo","volume":"75","author":"Kroon","year":"2015","journal-title":"Prostate"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1167\/iovs.03-0351","article-title":"Oxidative stress affects the junctional integrity of retinal pigment epithelial cells","volume":"45","author":"Bailey","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00417-009-1139-x","article-title":"Constitutive and oxidative-stress-induced expression of vegf in the rpe are differently regulated by different mitogen-activated protein kinases","volume":"247","author":"Klettner","year":"2009","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"White, C.E., and Olabisi, R.M. (2017). Scaffolds for retinal pigment epithelial cell transplantation in age-related macular degeneration. J. Tissue Eng., 8.","DOI":"10.1177\/2041731417720841"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000357375","article-title":"Microdevice-based cell therapy for age-related macular degeneration","volume":"53","author":"Lu","year":"2014","journal-title":"Dev. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1016\/j.biomaterials.2012.07.033","article-title":"Generation of hesc-derived retinal pigment epithelium on biopolymer coated polyimide membranes","volume":"33","author":"Subrizi","year":"2012","journal-title":"Biomaterials"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/164_2016_22","article-title":"Corticosteroids and anti-complement therapy in retinal diseases","volume":"242","author":"Narayanan","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exer.2016.08.005","article-title":"Dexamethasone reverses the effects of high glucose on human retinal endothelial cell permeability and proliferation in vitro","volume":"151","author":"Stewart","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tyson, S.L., Bafna, S., Gira, J.P., Goldberg, D.F., Jones, J.J., Jones, M.P., Kim, J.K., Martel, J.M., Nordlund, M.L., and Piovanetti-Perez, I.K. (2018). Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J. Cataract Refract. Surg.","DOI":"10.1016\/j.jcrs.2018.09.023"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1038\/srep08627","article-title":"Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative amd","volume":"5","author":"Vakalis","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5612342","DOI":"10.1155\/2018\/5612342","article-title":"Intravitreal dexamethasone in patients with wet age-related macular degeneration resistant to anti-vegf: A prospective pilot study","volume":"2018","author":"Giancipoli","year":"2018","journal-title":"J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1016\/j.biomaterials.2012.07.029","article-title":"Corneal repair by human corneal keratocyte-reprogrammed ipscs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel","volume":"33","author":"Chien","year":"2012","journal-title":"Biomaterials"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13287-018-0848-7","article-title":"Expression profiling of cell-intrinsic regulators in the process of differentiation of human ipscs into retinal lineages","volume":"9","author":"Chuang","year":"2018","journal-title":"Stem Cell Res. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/2\/241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:24:35Z","timestamp":1760185475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/2\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["ijms20020241"],"URL":"https:\/\/doi.org\/10.3390\/ijms20020241","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]}}}